Scientists seek perfect dose for life-saving drug in ICU's sickest patients
NCT ID NCT04868188
Summary
This study aimed to understand how a common antifungal drug, voriconazole, behaves in the bodies of critically ill patients. Researchers measured drug levels in 32 adults with severe COVID-19 or flu who were on a life support machine called ECMO and had a serious fungal infection. The goal was to gather information to help doctors give the most effective and safest dose to future patients in similar situations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University Hospitals of Leicester
Leicester, United Kingdom
Conditions
Explore the condition pages connected to this study.